A multiple dose comparison of tiotropium inhalation capsules and salmeterol inhalation aerosol in a 12 week, randomized, double-blind, double-dummy parallel group study in patients with chronic obstructive pulmonary disease (COPD).

Trial Profile

A multiple dose comparison of tiotropium inhalation capsules and salmeterol inhalation aerosol in a 12 week, randomized, double-blind, double-dummy parallel group study in patients with chronic obstructive pulmonary disease (COPD).

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Mar 2007

At a glance

  • Drugs Salmeterol; Tiotropium bromide
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 27 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top